785754-29-2 Usage
Uses
Used in Drug Synthesis:
(1-ethylcyclopropyl)amine(SALTDATA: HCl) is used as a building block or intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the creation of new drugs with potential therapeutic benefits.
Used in Pharmaceuticals:
(1-ethylcyclopropyl)amine(SALTDATA: HCl) is used as an active pharmaceutical ingredient (API) in the development of new medications. Its specific properties may contribute to the efficacy and safety of these medications.
Used in Organic Chemistry Research:
(1-ethylcyclopropyl)amine(SALTDATA: HCl) is used as a research compound in organic chemistry to study its reactivity, stability, and potential interactions with other molecules. This research can lead to a better understanding of its applications and the development of new chemical processes.
It is important to handle and store (1-ethylcyclopropyl)amine(SALTDATA: HCl) with caution due to potential health and safety risks. Proper handling and storage protocols should be followed to minimize risks associated with this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 785754-29-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,5,7,5 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 785754-29:
(8*7)+(7*8)+(6*5)+(5*7)+(4*5)+(3*4)+(2*2)+(1*9)=222
222 % 10 = 2
So 785754-29-2 is a valid CAS Registry Number.
785754-29-2Relevant articles and documents
SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
-
Paragraph 00537, (2021/04/01)
The invention provides substituted imidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.
HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page 77-78, (2010/02/07)
The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.
